Hensoldt's €1.5bn Order Blitz Masks a Sharply Weakening Cash Flow as €1bn Capacity Drive Kicks In

Defence electronics firm Hensoldt sees record €9.8B backlog but stock drops 11% below moving average; negative free cash flow and heavy investment costs worry investors ahead of May 22 AGM.

Hensoldt heads into its virtual annual general meeting on 22 May with a growth story that could hardly look more compelling on paper — and a stock that keeps falling. The defence electronics group booked a record order intake of nearly €1.5 billion in the first quarter, pushing its backlog to an unprecedented €9.8 billion. Yet the shares trade at €75.94, more than 11% below their 200-day moving average and a third off the 52-week high of €115.10.

The market’s reluctance is rooted in a stark disconnect between operational momentum and financial reality. While revenue surged 25% to €496 million in Q1 and the optronics division posted record margins, free cash flow turned negative. The cash conversion rate — the proportion of adjusted EBITDA that becomes free cash flow — collapsed to roughly 40% from 77% a year earlier. Fewer customer advance payments and a deliberate ramp-up in investment are draining liquidity.

That investment programme is massive: Hensoldt plans to spend around €1 billion through 2027 on expanding industrial capacity. In Aalen, a new production and development site for optronics is being built. The company intends to hire roughly 1,600 new staff this year, an increase of nearly 18% on today’s headcount, and expects to surpass 10,000 employees by the end of 2026. A long-term supply agreement securing access to nearly one million gallium nitride chips — a critical component for modern radar systems — underpins the ambition to lift 2030 revenue to €6 billion.

A National Security Bet with Near-Term Cost

Central to Hensoldt’s strategic push is the Bundeswehr’s luWES programme — an acronym for airborne effects in the electromagnetic spectrum. The company aims to deliver the core system, including a planned stand-off jammer, and position itself as a key supplier in electronic warfare. The programme is still in the bid phase, which leaves the stock exposed to execution risk until a contract materialises.

Germany’s defence budget is set to exceed €108 billion in 2026, and international opportunities such as a Canadian submarine programme worth more than €10 billion — with a decision expected in the first half of the year — underline the long-term demand for sensor technology. But investors are demanding proof that record order intakes translate into cash, not just capacity strain.

The current year guidance remains unchanged: revenue around €2.75 billion, an adjusted EBITDA margin of 18.5% to 19%, and a book-to-bill ratio of 1.5 to 2.0, meaning new orders will continue to outstrip sales by a wide margin. The first quarter already delivered a book-to-bill well above that range, driven by contracts for infantry fighting vehicles and Eurofighter radars.

Dividend as a Sideline, AGM as a Marker

The AGM on 22 May is expected to approve a dividend of €0.55 per share, up from €0.50 last year — a modest increase that provides clarity on profit distribution but does little to shift the narrative. The ex-dividend date is 25 May and payment is scheduled for 27 May. With the stock’s decline far outweighing the yield, the real focus lies elsewhere.

Analyst views reflect the divide. J.P. Morgan maintains a “Neutral” rating with a price target of €85, pointing to limited upside in the EBITDA margin band. Deutsche Bank is more bullish, keeping a target of €101 on the back of the record order book and robust NATO demand for defence electronics.

Technical indicators add to the confusion. The relative strength index stands at 82.3, suggesting an overbought condition despite the price drop — a contradiction that highlights how short-term fluctuations can distort signals in a volatile sector.

The Half-Year Report as the Real Test

The next major catalyst after the AGM is the half-year report on 31 July. By then, management will need to demonstrate that the record backlog is starting to convert into positive free cash flow. The €1 billion investment programme is a deliberate bet on future production volumes, but until the cash flow trajectory improves, the market is likely to keep discounting the stock.

In the meantime, Hensoldt’s story remains one of operating strength clashing with financial strain — a tension that will define the shares until the numbers catch up with the narrative.